A meeting of key managers and policy-makers in the administrative area where the survey was conducted should be held after all the data have been collected and analyzed. Summary tables and graphics should be prepared, and enough duplicates made to ensure that each participant has a copy. Invite all officials involved in drug use issues. For example, at the district level invite the district medical officer, district pharmacist, senior nurse, health service administrator, tutors of training schools, representatives from mission hospitals or other non-governmental organizations, and representative staff from the facilities surveyed.

Review with the group the purpose of the survey. Present the over-all summary results and compare these with other available results from previous studies in the country or with results from other countries reported in this manual (see Annex 3). Conduct a discussion on the overall pattern of results and reasons for any observed differences.

Circulate the graphics which demonstrate variation between facilities. Point out that the number of cases reviewed is limited, and that the differences may therefore not be as great as they appear. Ask participants to comment on why some facilities perform so differently, and discuss follow-up activities that could be conducted to explore these reasons. Point out that supervisory activities will have the greatest impact on those facilities with the greatest needs, identified by the indicators.

Discuss the possibility of carrying out simple indicator studies when routine supervision is undertaken. If there is interest in this concept, review briefly the procedures for using the indicators for monitoring and lot quality assurance sampling (Annex 4).

Record the issues reviewed during the discussion and whatever decisions are made. Discuss how the group could initiate a brainstorming session to identify what the next follow-up activities should be in light of this information.